TheraRadar
← Back
Data updated: Jul 17, 2026

California Department of Public Health (CDPH)

Biotech
Pharmaceuticals

California Department of Public Health (CDPH) is a biotechnology company with 1 FDA-approved products.

2003
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Biologics

California Department of Public Health (CDPH)'s Key Drugs

California Department of Public Health (CDPH)'s key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

California Department of Public Health (CDPH)'s Recent FDA Approvals

New NDA/BLA approvals for California Department of Public Health (CDPH) over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

California Department of Public Health (CDPH)'s Therapeutic Areas

Disease areas where California Department of Public Health (CDPH) has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

California Department of Public Health (CDPH) Pipeline Snapshot

Active clinical trials for California Department of Public Health (CDPH) across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • Top drug revenue breakdown
  • Drug-level revenue analysis

Trial Catalysts

  • Active trial monitoring
  • Phase 3 readout tracking

Patent Risk

  • Patent expiration timeline
  • Revenue at risk analysis

Compare Companies

  • Side-by-side pipeline analysis
  • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling